I did 6 months of B&R that finished June 2025
For informational purposes only
This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.
Thank you for sharing that information. It sounds like you've completed a significant course of treatment with B&R (bendamustine and rituximab) — that's a substantial commitment.
To help you best, I'd like to understand your situation better so I can provide relevant, personalized information:
A few clarifying questions:
-
What type of cancer are you being treated for? (This helps me reference the right clinical guidelines)
- Chronic lymphocytic leukemia (CLL)?
- Non-Hodgkin lymphoma (NHL)?
- Another blood cancer?
-
Where are you now in your treatment journey?
- Just finished in June 2025 — are you in a monitoring/surveillance phase?
- Did you have a recent scan or lab work to assess your response?
- Are you experiencing any side effects or concerns?
-
What would be most helpful to discuss?
- Understanding your current test results or scans?
- Preparing questions for your next oncology appointment?
- Learning about what to expect during the monitoring period?
- Understanding treatment options if there's disease progression?
Once I know more about your specific situation, I can help you understand your medical information, explore relevant guidelines, and prepare you for conversations with your care team.
This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.
This is general information.
Upload your records for guidance specific to YOUR diagnosis — personalized to your biomarkers, stage, and treatment history.
Get guidance specific to your case
This answer covers general information. For guidance based on YOUR records, biomarkers, and treatment history:
Related Questions
Er+ oligomet breast cancer. Have been 5aking ribocyclib for 14 months. Because of my low neutrophils the dose was...
I appreciate you sharing these details about your treatment journey. Let me help you understand what's happening and what questions to bring to your o
What signs of progression should I watch for
Based on NCCN Guidelines for Myeloproliferative Neoplasms, here are the key warning signs you should monitor and report to your oncologist: Blood Co
What questions should I ask my oncologist at my next appointment
I'd love to help you prepare for your appointment! To give you the most relevant questions, it would help to know a bit more about your situation: 1.
What are treatment options for KRAS G12A and PIK3CA mutations in colorectal cancer
Thank you for the follow-up. I want to address something important that emerged from your medical profile: Your actual diagnosis is a fibroblastic/my
What are treatment options for KRAS G12A and PIK3CA mutations in colorectal cancer
I appreciate your question about these specific mutations. However, I want to first clarify something important about your medical profile: Your Situ